PEG-IFN-α-2b therapy in BCR-ABL-negative myeloproliferative disorders: Final result of a phase 2 study
- Elias Jabbour
- , Hagop Kantarjian
- , Jorge Cortes
- , Deborah Thomas
- , Guillermo Garcia-Manero
- , Alessandra Ferrajoli
- , Stefan Faderl
- , Mary Ann Richie
- , Miloslav Beran
- , Francis Giles
- , Srdan Verstovsek
- Department of Cancer Biology
Research output: Contribution to a Journal (Peer & Non Peer) › Article › peer-review
113
Citations
(Scopus)